|4Jun 13, 7:33 PM ET

Anthera Pharmaceuticals Inc 4

4 · Anthera Pharmaceuticals Inc · Filed Jun 13, 2016

Insider Transaction Report

Form 4
Period: 2016-06-09
Dickinson Klara
SVP & Chief Regulatory Officer
Transactions
  • Award

    Stock option (right to buy)

    2016-06-09+105,000105,000 total
    Exercise: $3.52Exp: 2026-06-09Common Stock (105,000 underlying)
Footnotes (1)
  • [F1]This stock option vests monthly over four years beginning January 1, 2016 (the Vesting Start Date). The Stock Option is completely vested on the fourth anniversary of the vesting start date and will expire on June 9, 2026.

Documents

1 file
  • 4
    marketforms-35722.xmlPrimary

    PRIMARY DOCUMENT